Phase 3 Random Study of Pakritinib

The approval was accelerated for pakritinib at the moment there is this study underway globally for further support of the complete approval. This gives us a chance then to transition to momentum phase three study of mom and latin you're asking about that well I'm very excited about having more choices. There is a possibility of overlap in the future if mother and latin gets approved by june as we expect in the United States.